EPH receptor A2

Protein-coding gene in humans
EPHA2
Available structures
PDBOrtholog search: PDBe RCSB
List of PDB id codes

1MQB, 2E8N, 2K9Y, 2KSO, 2X10, 2X11, 3C8X, 3CZU, 3FL7, 3HEI, 3HPN, 3KKA, 3MBW, 3MX0, 3SKJ, 4P2K, 4PDO, 4TRL, 5EK7

Identifiers
AliasesEPHA2, Epha2, AW545284, Eck, Myk2, Sek-2, Sek2, ARCC2, CTPA, CTPP1, CTRCT6, EPH receptor A2, ECK
External IDsOMIM: 176946 MGI: 95278 HomoloGene: 20929 GeneCards: EPHA2
Gene location (Human)
Chromosome 1 (human)
Chr.Chromosome 1 (human)[1]
Chromosome 1 (human)
Genomic location for EPHA2
Genomic location for EPHA2
Band1p36.13Start16,124,337 bp[1]
End16,156,069 bp[1]
Gene location (Mouse)
Chromosome 4 (mouse)
Chr.Chromosome 4 (mouse)[2]
Chromosome 4 (mouse)
Genomic location for EPHA2
Genomic location for EPHA2
Band4 D3|4 73.67 cMStart141,028,551 bp[2]
End141,056,695 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • vagina

  • gallbladder

  • skin of abdomen

  • cervix epithelium

  • salivary gland

  • minor salivary glands

  • trachea

  • oral cavity

  • gums

  • parotid gland
Top expressed in
  • neural plate

  • lip

  • lens

  • hair follicle

  • jejunum

  • duodenum

  • esophagus

  • right lung

  • yolk sac

  • mesoderm
More reference expression data
BioGPS
More reference expression data
Gene ontology
Molecular function
  • nucleotide binding
  • protein kinase activity
  • transferase activity
  • kinase activity
  • protein binding
  • protein tyrosine kinase activity
  • ATP binding
  • ephrin receptor activity
  • transmembrane receptor protein tyrosine kinase activity
  • cadherin binding
  • virus receptor activity
  • transmembrane-ephrin receptor activity
Cellular component
  • integral component of membrane
  • cell projection
  • membrane
  • ruffle membrane
  • cell junction
  • lamellipodium membrane
  • leading edge membrane
  • focal adhesion
  • integral component of plasma membrane
  • intracellular anatomical structure
  • plasma membrane
  • lamellipodium
  • cell surface
  • neuron projection
  • receptor complex
  • tight junctions
Biological process
  • regulation of lamellipodium assembly
  • skeletal system development
  • negative regulation of protein kinase B signaling
  • cell differentiation
  • regulation of cell adhesion mediated by integrin
  • protein kinase B signaling
  • activation of GTPase activity
  • phosphorylation
  • transmembrane receptor protein tyrosine kinase signaling pathway
  • keratinocyte differentiation
  • vasculogenesis
  • multicellular organism development
  • protein phosphorylation
  • cell adhesion
  • blood vessel development
  • notochord morphogenesis
  • notochord cell development
  • angiogenesis
  • intrinsic apoptotic signaling pathway in response to DNA damage
  • neural tube development
  • neuron differentiation
  • notochord
  • regulation of ERK1 and ERK2 cascade
  • cell chemotaxis
  • post-anal tail morphogenesis
  • axial mesoderm formation
  • response to growth factor
  • viral process
  • cell migration
  • apoptotic process
  • peptidyl-tyrosine phosphorylation
  • osteoclast differentiation
  • osteoblast differentiation
  • regulation of angiogenesis
  • regulation of blood vessel endothelial cell migration
  • ephrin receptor signaling pathway
  • lens fiber cell morphogenesis
  • mammary gland epithelial cell proliferation
  • bone remodeling
  • branching involved in mammary gland duct morphogenesis
  • negative regulation of cytokine production
  • defense response to Gram-positive bacterium
  • negative regulation of lymphangiogenesis
  • blood vessel endothelial cell proliferation involved in sprouting angiogenesis
  • pericyte cell differentiation
  • negative regulation of angiogenesis
  • inflammatory response
  • negative regulation of chemokine production
  • blood vessel morphogenesis
  • cAMP metabolic process
  • cell motility
  • viral entry into host cell
  • positive regulation of protein localization to plasma membrane
  • axon guidance
  • protein localization to plasma membrane
  • positive regulation of bicellular tight junction assembly
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

1969

13836

Ensembl

ENSG00000142627

ENSMUSG00000006445

UniProt

P29317

Q03145

RefSeq (mRNA)

NM_004431
NM_001329090

NM_010139

RefSeq (protein)

NP_001316019
NP_004422

NP_034269

Location (UCSC)Chr 1: 16.12 – 16.16 MbChr 4: 141.03 – 141.06 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

EPH receptor A2 (ephrin type-A receptor 2) is a protein that in humans is encoded by the EPHA2 gene.[5][6]

Function

This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into two groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands.[6]

Clinical significance

It may be implicated in BRAF mutated melanomas becoming resistant to BRAF-inhibitors and MEK inhibitors.[7] It is also the receptor by which Kaposi's sarcoma-associated herpesvirus (KSHV) enters host cells; small molecule inhibitors of EphA2 have shown some ability to block KSHV entry into human cells.[8]

Interactions

EPH receptor A2 has been shown to interact with:

It was also shown that doxazosin is a small molecule agonist of EPH receptor A2.[13]

See also

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000142627 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000006445 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Sulman EP, Tang XX, Allen C, Biegel JA, Pleasure DE, Brodeur GM, Ikegaki N (April 1997). "ECK, a human EPH-related gene, maps to 1p36.1, a common region of alteration in human cancers". Genomics. 40 (2): 371–4. doi:10.1006/geno.1996.4569. PMID 9119409.
  6. ^ a b "Entrez Gene: EPHA2 EPH receptor A2".
  7. ^ "Counteracting Drug Resistance in Melanoma". 2015. Archived from the original on 2015-02-04. Retrieved 2015-02-04.
  8. ^ Hahn AS, Kaufmann JK, Wies E, Naschberger E, Panteleev-Ivlev J, Schmidt K, Holzer A, Schmidt M, Chen J, König S, Ensser A, Myoung J, Brockmeyer NH, Stürzl M, Fleckenstein B, Neipel F (2012). "The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus". Nat. Med. 18 (6): 961–6. doi:10.1038/nm.2805. PMC 3645317. PMID 22635007.
  9. ^ Himanen JP, Goldgur Y, Miao H, Myshkin E, Guo H, Buck M, Nguyen M, Rajashankar KR, Wang BC, Nikolov DB (July 2009). "Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex". EMBO Rep. 10 (7): 722–8. doi:10.1038/embor.2009.91. PMC 2727437. PMID 19525919.
  10. ^ Kikawa KD, Vidale DR, Van Etten RL, Kinch MS (October 2002). "Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation". J. Biol. Chem. 277 (42): 39274–9. doi:10.1074/jbc.M207127200. PMID 12167657.
  11. ^ a b Pratt RL, Kinch MS (October 2002). "Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade". Oncogene. 21 (50): 7690–9. doi:10.1038/sj.onc.1205758. PMID 12400011. S2CID 7083192.
  12. ^ Pandey A, Lazar DF, Saltiel AR, Dixit VM (December 1994). "Activation of the Eck receptor protein tyrosine kinase stimulates phosphatidylinositol 3-kinase activity". J. Biol. Chem. 269 (48): 30154–7. doi:10.1016/S0021-9258(18)43790-8. PMID 7982920.
  13. ^ Petty A, Myshkin E, Qin H, Guo H, Miao H, Tochtrop GP, Hsieh JT, Page P, Liu L, Lindner DJ, Acharya C, MacKerell AD, Ficker E, Song J, Wang BC (August 2012). "A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo". PLOS ONE. 7 (8): e42120. Bibcode:2012PLoSO...742120P. doi:10.1371/journal.pone.0042120. PMC 3419725. PMID 22916121.

Further reading

  • Flanagan JG, Vanderhaeghen P (1998). "The ephrins and Eph receptors in neural development". Annu. Rev. Neurosci. 21: 309–45. doi:10.1146/annurev.neuro.21.1.309. PMID 9530499. S2CID 1278600.
  • Zhou R (1998). "The Eph family receptors and ligands". Pharmacol. Ther. 77 (3): 151–81. doi:10.1016/S0163-7258(97)00112-5. PMID 9576626.
  • Holder N, Klein R (1999). "Eph receptors and ephrins: effectors of morphogenesis". Development. 126 (10): 2033–44. doi:10.1242/dev.126.10.2033. PMID 10207129.
  • Wilkinson DG (2000). "Eph receptors and ephrins: regulators of guidance and assembly". Int. Rev. Cytol. International Review of Cytology. 196: 177–244. doi:10.1016/S0074-7696(00)96005-4. ISBN 9780123646002. PMID 10730216.
  • Xu Q, Mellitzer G, Wilkinson DG (2000). "Roles of Eph receptors and ephrins in segmental patterning". Philos. Trans. R. Soc. Lond. B Biol. Sci. 355 (1399): 993–1002. doi:10.1098/rstb.2000.0635. PMC 1692797. PMID 11128993.
  • Wilkinson DG (2001). "Multiple roles of EPH receptors and ephrins in neural development". Nat. Rev. Neurosci. 2 (3): 155–64. doi:10.1038/35058515. PMID 11256076. S2CID 205014301.
  • Kinch MS, Carles-Kinch K (2003). "Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer". Clin. Exp. Metastasis. 20 (1): 59–68. doi:10.1023/A:1022546620495. PMID 12650608. S2CID 2472961.
  • Walker-Daniels J, Hess AR, Hendrix MJ, Kinch MS (2003). "Differential regulation of EphA2 in normal and malignant cells". Am. J. Pathol. 162 (4): 1037–42. doi:10.1016/S0002-9440(10)63899-0. PMC 1851246. PMID 12651595.
  • Lindberg RA, Hunter T (1990). "cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases". Mol. Cell. Biol. 10 (12): 6316–24. doi:10.1128/mcb.10.12.6316. PMC 362907. PMID 2174105.
  • Pandey A, Shao H, Marks RM, Polverini PJ, Dixit VM (1995). "Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis". Science. 268 (5210): 567–9. Bibcode:1995Sci...268..567P. doi:10.1126/science.7536959. PMID 7536959.
  • Pandey A, Duan H, Dixit VM (1995). "Characterization of a novel Src-like adapter protein that associates with the Eck receptor tyrosine kinase". J. Biol. Chem. 270 (33): 19201–4. doi:10.1074/jbc.270.33.19201. PMID 7543898.
  • Ruiz JC, Robertson EJ (1994). "The expression of the receptor-protein tyrosine kinase gene, eck, is highly restricted during early mouse development". Mech. Dev. 46 (2): 87–100. doi:10.1016/0925-4773(94)90078-7. PMID 7918100. S2CID 21419336.
  • Davis S, Gale NW, Aldrich TH, Maisonpierre PC, Lhotak V, Pawson T, Goldfarb M, Yancopoulos GD (1994). "Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity". Science. 266 (5186): 816–9. Bibcode:1994Sci...266..816D. doi:10.1126/science.7973638. PMID 7973638.
  • Pandey A, Lazar DF, Saltiel AR, Dixit VM (1994). "Activation of the Eck receptor protein tyrosine kinase stimulates phosphatidylinositol 3-kinase activity". J. Biol. Chem. 269 (48): 30154–7. doi:10.1016/S0021-9258(18)43790-8. PMID 7982920.
  • Ganju P, Shigemoto K, Brennan J, Entwistle A, Reith AD (1994). "The Eck receptor tyrosine kinase is implicated in pattern formation during gastrulation, hindbrain segmentation and limb development". Oncogene. 9 (6): 1613–24. PMID 8183555.
  • Gale NW, Holland SJ, Valenzuela DM, Flenniken A, Pan L, Ryan TE, Henkemeyer M, Strebhardt K, Hirai H, Wilkinson DG, Pawson T, Davis S, Yancopoulos GD (1996). "Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis". Neuron. 17 (1): 9–19. doi:10.1016/S0896-6273(00)80276-7. PMID 8755474. S2CID 1075856.
  • Kozlosky CJ, VandenBos T, Park L, Cerretti DP, Carpenter MK (1997). "LERK-7: a ligand of the Eph-related kinases is developmentally regulated in the brain". Cytokine. 9 (8): 540–9. doi:10.1006/cyto.1997.0199. PMID 9245480.
  • Ephnomenclaturecommittee (1997). "Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee". Cell. 90 (3): 403–4. doi:10.1016/S0092-8674(00)80500-0. PMID 9267020. S2CID 26773768.

External links

  • Overview of all the structural information available in the PDB for UniProt: P29317 (Human Ephrin type-A receptor 2) at the PDBe-KB.
  • Overview of all the structural information available in the PDB for UniProt: Q03145 (Mouse Ephrin type-A receptor 2) at the PDBe-KB.
  • v
  • t
  • e
  • 1mqb: Crystal Structure of Ephrin A2 (ephA2) Receptor Protein Kinase
    1mqb: Crystal Structure of Ephrin A2 (ephA2) Receptor Protein Kinase
  • v
  • t
  • e
Growth factor receptors
EGF receptor family
Insulin receptor family
PDGF receptor family
FGF receptor family
VEGF receptors family
HGF receptor family
Trk receptor family
EPH receptor family
LTK receptor family
TIE receptor family
ROR receptor family
DDR receptor family
PTK7 receptor family
RYK receptor family
MuSK receptor family
ROS receptor family
AATYK receptor family
AXL receptor family
RET receptor family
uncategorised
ABL family
ACK family
CSK family
FAK family
FES family
FRK family
JAK family
SRC-A family
SRC-B family
TEC family
  • TEC
  • BMX
  • BTK
  • ITK
  • TXK
SYK family
  • v
  • t
  • e
Angiopoietin
  • Kinase inhibitors: Altiratinib
  • CE-245677
  • Rebastinib
CNTF
EGF (ErbB)
EGF
(ErbB1/HER1)
ErbB2/HER2
  • Agonists: Unknown/none
ErbB3/HER3
ErbB4/HER4
FGF
FGFR1
FGFR2
  • Antibodies: Aprutumab
  • Aprutumab ixadotin
FGFR3
FGFR4
Unsorted
HGF (c-Met)
IGF
IGF-1
  • Kinase inhibitors: BMS-754807
  • Linsitinib
  • NVP-ADW742
  • NVP-AEW541
  • OSl-906
IGF-2
  • Antibodies: Dusigitumab
  • Xentuzumab (against IGF-1 and IGF-2)
Others
  • Cleavage products/derivatives with unknown target: Glypromate (GPE, (1-3)IGF-1)
  • Trofinetide
LNGF (p75NTR)
  • Aptamers: Against NGF: RBM-004
  • Decoy receptors: LEVI-04 (p75NTR-Fc)
PDGF
RET (GFL)
GFRα1
GFRα2
GFRα3
GFRα4
Unsorted
  • Kinase inhibitors: Agerafenib
SCF (c-Kit)
TGFβ
  • See here instead.
Trk
TrkA
  • Negative allosteric modulators: VM-902A
  • Aptamers: Against NGF: RBM-004
  • Decoy receptors: ReN-1820 (TrkAd5)
TrkB
TrkC
VEGF
Others
Portal:
  • icon Biology


Stub icon

This article on a gene on human chromosome 1 is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e